Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Head and Neck Cancer

Free Subscription 02.11.2026 1 Am J Surg 3 Ann Otol Rhinol Laryngol 6 Anticancer Res 6 BMC Cancer 1 BMC Surg 1 Br J Oral Maxillofac Surg 2 Dis Esophagus 1 Head Neck 2 HNO 1 Int J Cancer 1 J Clin Oncol 1 Laryngoscope 1 Oral Oncol 1 PLoS One 1 Proc Natl Acad Sci U S A 1 Radiother Oncol 3 Surgery

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg

1. LONDONO E, Green R, HoSang K, Gao TP, et al
   Increased risk of hypocalcemia and RLN injury in patients with medullary thyroid carcinoma after thyroidectomy.
   Am J Surg. 2026;263:117296.
   PubMed         Abstract available
   
   

   
   Ann Otol Rhinol Laryngol

2. CARLINI A, Berti M, Lamberti G, Andrini E, et al
   Refining Prognostic Stratification in Head and Neck Paragangliomas: Insights from a SEER-Based Population Study.
   Ann Otol Rhinol Laryngol. 2026;135:959-967.
   PubMed         Abstract available
   
   
3. NACHALON Y, Nativ-Zeltzer N, Schaberg KB, Belafsky PC, et al
   Esophageal Squamous Papilloma in the Practice of Otolaryngology: A Case Series and Diagnostic Considerations for the otolaryngologist.
   Ann Otol Rhinol Laryngol. 2026;135:954-958.
   PubMed         Abstract available
   
   
4. BHASKARA M, Chestnut EH, Molden B, Chen DW, et al
   Deep Cervical Lipomas: Case Series and Scoping Review of the Literature.
   Ann Otol Rhinol Laryngol. 2026;135:901-921.
   PubMed         Abstract available
   
   

   
   Anticancer Res

5. PAPANASTASIOU G, Chrysovergis A, Papanikolaou V, Spyropoulou D, et al
   mTOR Inhibition Strategies in Oropharyngeal Carcinoma.
   Anticancer Res. 2026;46:5947-5954.
   PubMed         Abstract available
   
   
6. AIHARA Y, Tanaka H, Hihara K, Hanyu K, et al
   Clinical Outcomes of Postoperative Three-weekly Cisplatin for High-risk Head and Neck Squamous Cell Carcinoma.
   Anticancer Res. 2026;46:6287-6296.
   PubMed         Abstract available
   
   
7. HISANO O, Yoshitake T, Matsumoto K, Shirakawa Y, et al
   Definitive Chemoradiotherapy Following Preoperative Induction Chemotherapy in Esophageal Squamous Cell Carcinoma: Prognostic Impact of Response.
   Anticancer Res. 2026;46:6235-6248.
   PubMed         Abstract available
   
   
8. ISHIDA Y, Yuasa R, Nakamuta K, Wada T, et al
   Abscopal-like Regression of Lung Metastases After Near-infrared Photoimmunotherapy Plus Nivolumab in Laryngeal Carcinoma.
   Anticancer Res. 2026;46:6457-6465.
   PubMed         Abstract available
   
   
9. LIN MH, Chong YB, Chung CL, Chen MY, et al
   Bardoxolone Methyl Induces Partially Caspase-dependent Apoptosis of Oral Squamous Cell Carcinoma Cells.
   Anticancer Res. 2026;46:6125-6140.
   PubMed         Abstract available
   
   
10. HUANG YC, Wang CC, Lan YY
    The Tyro3 Inhibitor UNC9426 Induces Apoptosis in OEC-M1 OSCC Cells.
    Anticancer Res. 2026;46:6155-6168.
    PubMed         Abstract available
    
    

    
    BMC Cancer

11. MONEM MOHARRER S, Musaie F, Kiani K, Salighehrad M, et al
    Artificial intelligence in malignant risk assessment of oral lesions: an umbrella review.
    BMC Cancer. 2026;26:1330.
    PubMed         Abstract available
    
    
12. TOPKAN E, Somay E, Bascil S, Selek U, et al
    The Oxygenation-Nutritional-Inflammatory (ONI) index and the risk of osteoradionecrosis of the jaw in locally advanced nasopharyngeal carcinoma: a continuous multidimensional modeling analysis.
    BMC Cancer. 2026;26:1325.
    PubMed         Abstract available
    
    
13. XIE R, Lin X, Li Q, Pan J, et al
    Comparative efficacy and toxicity of two versus three induction chemotherapy cycles in locally advanced nasopharyngeal carcinoma: a propensity score matching analysis.
    BMC Cancer. 2026;26:1322.
    PubMed         Abstract available
    
    
14. RUAN Y, Cao W, Long C, Li C, et al
    Locoregional and distant recurrence after neoadjuvant chemoimmunotherapy versus chemoradiotherapy in esophageal squamous cell carcinoma: a focused meta-analysis.
    BMC Cancer. 2026;26:1287.
    PubMed         Abstract available
    
    
15. MENG C, Su H, Yan R, Sun R, et al
    An R-loop-related gene signature predicts prognosis and shapes the immune microenvironment in esophageal squamous cell carcinoma.
    BMC Cancer. 2026;26:1288.
    PubMed         Abstract available
    
    
16. SU YS, Shen JH, Fang KH, Tsai MH, et al
    A disease-specific immunonutritional model for prognostic stratification in oral cavity squamous cell carcinoma.
    BMC Cancer. 2026;26:1274.
    PubMed         Abstract available
    
    

    
    BMC Surg

17. OSMAN IM, Peng S, Liu H, Zhen W, et al
    Neoadjuvant immunotherapy for locally advanced resectable gastric and gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis.
    BMC Surg. 2026;26:719.
    PubMed         Abstract available
    
    

    
    Br J Oral Maxillofac Surg

18. UBHI J, Wilkinson S, Sahovaler A, Wilkinson J, et al
    Contralateral sentinel node drainage patterns in early lateralised oral squamous cell carcinoma - a retrospective study.
    Br J Oral Maxillofac Surg. 2026;64:787-793.
    PubMed         Abstract available
    
    

    
    Dis Esophagus

19. BOLGER JC, Allison F, Wakeam E, Yeung JC, et al
    Intraoperative impedance planimetry for assessment of pyloric function in minimally invasive esophagectomy.
    Dis Esophagus. 2026;39:doag120.
    PubMed         Abstract available
    
    
20. JIAO W, Wang X, Zhang F, Li D, et al
    Postoperative radiotherapy after resection of esophageal small-cell neuroendocrine carcinoma: a multicenter retrospective cohort study.
    Dis Esophagus. 2026;39:doag121.
    PubMed         Abstract available
    
    

    
    Head Neck

21. SERT KY, Sundaresan P, Charters E, Venchiarutti R, et al
    Lymphoedema in Head and Neck Cancer Survivors: Healthcare Professionals' Perspectives.
    Head Neck. 2026 Oct 23. doi: 10.1002/hed.70526.
    PubMed         Abstract available
    
    

    
    HNO

22. BRAND M, Hoffmann TK, Laban S
    [Update on immunotherapy in head and neck cancer : New aspects from the ASCO annual meeting 2026].
    HNO. 2026 Oct 27. doi: 10.1007/s00106-026-01823.
    PubMed         Abstract available
    
    
23. SCHNELLHARDT S, Tribius S, Linxweiler M, Suss C, et al
    [Radiotherapy of head and neck cancer : Highlights from the 2026 ASCO Annual Meeting].
    HNO. 2026 Oct 28. doi: 10.1007/s00106-026-01817.
    PubMed         Abstract available
    
    

    
    Int J Cancer

24. HURT C, Park S, Chambers J, Brammer C, et al
    The Use of Combination Palliative Radiotherapy and Single-Agent Immunotherapy for the Management of Head and Neck Squamous Cell Carcinoma (HNSCC) in the United Kingdom (UK).
    Int J Cancer. 2026 Oct 23. doi: 10.1002/ijc.70802.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

25. PENG Z, Wang J, Zhang Y, Li H, et al
    First-Line Retlirafusp Alfa Plus Chemotherapy for Human Epidermal Growth Factor Receptor 2-Negative Gastric or Gastroesophageal Junction Adenocarcinoma: A Randomized, Double-Blind, Phase III Study (RELIGHT).
    J Clin Oncol. 2026;44:3015-3025.
    PubMed         Abstract available
    
    

    
    Laryngoscope

26. SYED Z, Peralta F, Porto-Gutierrez F, Chen R, et al
    Management of Carotid Blowout Syndrome After Head and Neck Cancer: A National Readmissions Analysis.
    Laryngoscope. 2026 Oct 29. doi: 10.1002/lary.71000.
    PubMed        
    
    

    
    Oral Oncol

27. XIE Y, Lin Y, He J, Ji Y, et al
    Mechanism study on CSF3-Induced M2 polarization of tumor-associated macrophages and CCL9 secretion in promoting tumor progression in head and neck squamous cell carcinoma.
    Oral Oncol. 2026;183:108176.
    PubMed         Abstract available
    
    

    
    PLoS One

28. HE L, Huang X, Huang P
    Identification of prognostic biomarkers for nasopharyngeal carcinoma through microRNA?mRNA network analysis combined with screening of immune?related genes.
    PLoS One. 2026;21:e0361607.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

29. PIGNATARO AM, Schwarz CC, Wiechec E, Cordiale A, et al
    An innervated and vascularized HNSCC-on-a-chip model built on defined and tunable engineered extracellular matrices.
    Proc Natl Acad Sci U S A. 2026;123:e2602541123.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

30. DRAGAN T, Duprez F, Digonnet A, Mootassim-Billah S, et al
    Patient reported swallowing outcomes after prophylactic versus reactive gastrostomy during chemoradiotherapy for head and neck cancer: Results from the SwallPEG randomized trial.
    Radiother Oncol. 2026 Oct 28:111835. doi: 10.1016/j.radonc.2026.111835.
    PubMed         Abstract available
    
    

    
    Surgery

31. LAZIM A, Alzumaili B, Xu B, Instrum R, et al
    Pathologic diagnosis of thyroid nodules with preoperatively detected tumor protein 53 mutations: A tricenter series of 32 cases.
    Surgery. 2026;199:110536.
    PubMed         Abstract available
    
    
32. CHEN WC, Tsai CH, Leu YS, Kuo CY, et al
    Predicting biochemical hypothyroidism after thyroid lobectomy using ultrasound elastography.
    Surgery. 2026;199:110530.
    PubMed         Abstract available
    
    
33. PENNESTRI F, Procopio PF, Santoro G, Laurino A, et al
    Toward risk-adapted surgical de-escalation in sporadic medullary thyroid carcinoma: Integrating desmoplastic stromal reaction, nodal status, and multifocality.
    Surgery. 2026;202:110732.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum